Cargando…

Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

Abnormal liver enzymes are seen in 20% of hospitalized patients with COVID-19. The etiology of elevated liver enzymes is thought to be multifactorial including medications and underlying liver disease. The true prevalence and clinical significance of underlying chronic liver diseases (CLD) in COVID-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kovalic, Alexander J., Satapathy, Sanjaya K., Thuluvath, Paul J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386238/ https://www.ncbi.nlm.nih.gov/pubmed/32725453 http://dx.doi.org/10.1007/s12072-020-10078-2

Ejemplares similares

What GI Physicians Need to Know During COVID-19 Pandemic
por: Thuluvath, Paul J., et al.
Publicado: (2020)

Liver injury in COVID-19: The hepatic aspect of the respiratory syndrome — what we know so far
por: Anirvan, Prajna, et al.
Publicado: (2020)

Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect
por: Heda, Rajiv, et al.
Publicado: (2021)

Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases
por: Thuluvath, Paul J., et al.
Publicado: (2021)

Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease
por: Bernstein, David, et al.
Publicado: (2021)

Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta‐Analysis
por: Young, Steven, et al.
Publicado: (2020)

Clinical and Genetic Risk Factors of Recurrent Nonalcoholic Fatty Liver Disease After Liver Transplantation
por: Satapathy, Sanjaya K., et al.
Publicado: (2021)

Gastrointestinal and Liver Manifestations of COVID-19
por: Agarwal, Amol, et al.
Publicado: (2020)

Tu1256: METFORMIN USE IS ASSOCIATED WITH LESS FREQUENT SEVERE LIVER INJURY UPON HOSPITAL ADMISSIN WITH COVID-19
por: Kuntzen, Christian, et al.
Publicado: (2022)

Vaccination in Chronic Liver Disease: An Update
por: Alukal, Joseph J., et al.
Publicado: (2022)

Risk factors and outcomes for acute-on-chronic liver failure in COVID-19: a large multi-center observational cohort study
por: Satapathy, Sanjaya K., et al.
Publicado: (2021)

Outcomes after Liver Transplantation with Steatotic Grafts: Redefining Acceptable Cutoffs for Steatotic Grafts
por: Da, Ben L, et al.
Publicado: (2022)

Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
por: Bernstein, David, et al.
Publicado: (2022)

Accuracy of Noninvasive Fibrosis Scoring Systems in African American and White Patients With Nonalcoholic Fatty Liver Disease
por: Marella, Hemnishil K., et al.
Publicado: (2020)

Modified EASL-CLIF criteria that is easier to use and perform better to prognosticate acute-on-chronic liver failure
por: Thuluvath, Paul J, et al.
Publicado: (2022)

Survival Outcomes Are Not Affected When Liver Transplant Surgery Is Done at Night, During Weekends, or Summer Months
por: Thuluvath, Paul J., et al.
Publicado: (2019)

Association of non-alcoholic fatty liver disease and COVID-19: A literature review of current evidence
por: Anirvan, Prajna, et al.
Publicado: (2021)

Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure
por: Satapathy, Sanjaya K., et al.
Publicado: (2023)

Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
por: Chauhan, Mahak, et al.
Publicado: (2022)

Gender and ethnic differences in the post-liver transplant outcomes of patients with autoimmune hepatitis with acute liver failure at initial presentation: a case-control study
por: Thuluvath, Paul J., et al.
Publicado: (2015)

N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies
por: Amjad, Waseem, et al.
Publicado: (2021)

94: ANTIBODY RESPONSE AFTER A BOOSTER DOSE OF SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS AND THOSE WITH CHRONIC LIVER DISEASES
por: Chauhan, Mahak, et al.
Publicado: (2022)

Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction
por: Sikander, Mohammed, et al.
Publicado: (2020)

Prevalence, Risk Factors, and Outcomes of Hospitalized Patients With Coronavirus Disease 2019 Presenting as Acute Pancreatitis
por: Inamdar, Sumant, et al.
Publicado: (2020)

Prevalence and outcomes of chronic liver disease in patients receiving dialysis: systematic review and meta-analysis
por: Swift, Oscar, et al.
Publicado: (2021)

Clinical Determinants of Severe COVID-19 Disease – A Systematic Review and Meta-Analysis
por: Sahu, Ankit Kumar, et al.
Publicado: (2021)

A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis
por: Ganguli, Surosree, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille?
por: Singh, Shivaram P., et al.
Publicado: (2021)

Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics
por: Thuluvath, Paul J., et al.
Publicado: (2020)

Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis
por: Badal, Sujan, et al.
Publicado: (2021)

Longitudinal Renal Function in Liver Transplant Recipients With Acute-on-Chronic Liver Failure
por: Yazawa, Masahiko, et al.
Publicado: (2020)

Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study
por: Agbim, Uchenna, et al.
Publicado: (2020)

Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid
por: Satapathy, Sanjaya K., et al.
Publicado: (2017)

A large randomized clinical trial is necessary to establish the role of camrelizumab in hepatocellular carcinoma
por: Ravindran, Nishal, et al.
Publicado: (2020)

Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis
por: Huang, Zhen, et al.
Publicado: (2021)

Acute on Chronic Liver Failure: Factors Associated With Transplantation
por: Goussous, Naeem, et al.
Publicado: (2021)

Markers of liver injury and clinical outcomes in COVID-19 patients: A systematic review and meta-analysis
por: Kunutsor, Setor K., et al.
Publicado: (2021)

Sarcopenia is associated with poor clinical outcomes in patients with inflammatory bowel disease: a prospective cohort study
por: Liu, Sifan, et al.
Publicado: (2022)

Liver injury following SARS-CoV-2 vaccination: A multicenter case series
por: Shroff, Hersh, et al.
Publicado: (2022)

Rising alcohol-associated liver disease–related mortality rates in the United States from 1999 to 2022
por: Ilyas, Fariha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6phc9jb9qccduaef8m9t08b7jv